Jose Debes MD PhD is a Professor in Medicine at the University of Minnesota in Minneapolis. His work centers on mechanisms of hepatitis-related liver cancer as well as awareness on risk factors for hepatitis B and liver cancer. He founded and leads two research networks in Latin America and in Africa
Dr. Hoshida is Professor of Internal Medicine at University of Texas Southwestern Medical Center. He is a hepatologist and physician scientist with expertise in translational research in liver cirrhosis and cancer with a specific focus on risk prediction, disease classification, and chemoprevention/therapeutic discovery.
Natalie J. Torok is a physician-scientist at Stanford University and the VA Palo Alto. The Torok lab's primary research interests are in the pathomechanisms of liver fibrosis and matrix remodeling and exploring translational aspects to prevent liver disease progression. Metabolic dysfunction associated steatohepatitis (MASH) is becoming the leading cause of chronic liver disease and liver cancer, and her lab is interested in deciphering how dynamic changes in the liver matrix accelerate this process in certain conditions such as type 2 diabetes.
Dr. Malhi is a consultant in the Division of Gastroenterology and Hepatology with a joint appointment in Physiology and a Professor of Medicine and Physiology at Mayo Clinic, Rochester, MN. She currently serves as the Vice Chair for the division of Gastroenterology and Hepatology. Dr. Malhi's laboratory studies lipotoxic endoplasmic reticulum stress, with particular research interest in mechanisms of liver injury and inflammation in nonalcoholic steatohepatitis pathogenesis.
Dr. Ibrahim is a Professor of Pediatrics and Physiology; she is a pediatric transplant hepatologist and a physician scientist. Samar is the Principal Investigator of the NIH-funded lipotoxicity and liver inflammation laboratory at Mayo Clinic. She studies mechanisms of liver injury and inflammation in metabolic dysfunction associated steatohepatitis (MASH) with the goal to identify novel biomarkers and mechanism-based therapeutic targets.
BC Sharma
Director Professor
Department of Gastroenterology and Hepatology
GIPMER, New Delhi
India
Research Fields
- Hepatic EncephalopathyY
- Portal Hypertension
Publications: 260 ( in leading journals like NEJM, Gastroenterology, Hepatology, J Hepatol and Gut)
- President APASL 2017-18
- President INASL 2026-27
- Asst Editor Hepatol International
- Member of National and International Journals Editorial Board
More than 100 National and International Fellowships and Awards
Dr. Patricia Bloom is an Assistant Professor and transplant hepatologist at the Mayo Clinic. She performs clinical and translational research to improve outcomes in decompensated cirrhosis, especially for hepatic encephalopathy. Her goals are to create and test innovative microbiome therapies to treat hepatic encephalopathy. She is also developing innovative technology solutions for the management of decompensated cirrhosis. She serves as an Associate Editor for Hepatology Communications and is Chair Elect of the Communications and Technology Committee of AASLD.
Dr. Goel is an Associate Professor of Medicine at Stanford University. She is a transplant hepatologist in the Division of Gastroenterology and Hepatology with a specific clinical and research interest in autoimmune liver diseases including autoimmune hepatitis, PSC and PBC. She serves as the PI on several clinical trials related to these diseases. She is the Program Director of the ACGME Transplant Hepatology Fellowship and the Associate Program Director of the Gastroenterology Fellowship at Stanford.
Dr. Shah serves as the Mr. and Mrs. Ronald F. Kinney Executive Dean of Research Honoring Ronald F. Kinney, Jr. and the Carol M. Gatton Professor of Digestive Diseases Research, Honoring Peter Carryer, M.D. at Mayo Clinic in Rochester. He has been on staff at Mayo Clinic for 30 years and previously served as Chairs of the Division of Gastroenterology and Hepatology and Department of Medicine. Dr.
Pranoti Mandrekar, PhD, Professor and Associate Vice-Chair of Faculty Development, Dept of Medicine in the Division of Gastroenterology and Program director, Translational Science Program, Graduate School of Biomedical Sciences and Director, Junior Faculty Development Program UMass Chan Medical School (UMCMS). Dr. Mandrekar's research focuses on investigating the mechanisms of alcohol-mediated liver disease, specifically inflammation and fibrosis.